Clinical application: Brain nerve ×‌↓÷damage

S100-β protein, as a neurospec<♣ific serum marker, isγ↕σ¶ highly specific for↕>ε the assessment of central nerv→×€↔ous system vascular disea¶₽ses, and can be used as a→π≤ predictor of the sever±©ity and prognosis of cerebrovascular£ε✔-related diseases. The‌σ detection of S100-β protein concentration in s↓↕erum and cerebrospinal fluid canφ→¥✔ be used as a laboratory indicator for✔≥ secondary brain injury and pro™✔gnosis assessment, and caσ♠∏ n provide reference for  δclinical timely and effe₹÷ctive medical intervention.

Bedside cranial nerve injury detection¥♦ project of LEHE：S100-β

By detecting the concentration of ☆ serum S100-β protein, it can reflect ♣✘the severity and prognosis≈₽£ of brain tissue injury and t±≥≈he integrity of blo>≈×od-brain barrier.

Disease

Clinical application

LEHE Products

1.  Ischemic stroke

2. Cerebral hemorrhage

3. Subarachnoid hemorrhag£‍☆βe

1. Assess the severity of brain±♠ damage, predict the size and prognosi≤γs of ischemic stroke

S100-β

2. An indicator of early neurol​​ogical deficits to a≠β≥σssess vascular diseases of the cen↕↑'tral nervous system